NEW YORK, Nov. 3, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
US Tumor Marker Testing Market
http://www.reportlinker.com/p0591360/US-Tumor-Marker-Testing-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
Highlights
- Comprehensive 620-page analysis of the US tumor marker testing market.
- Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
- Ten-year test volume and sales forecasts over for 40 tumor marker performed in US hospitals, commercial laboratories and physician offices.
- Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.
- Current instrumentation technologies and feature comparison of leading analyzers.
- Sales and market shares of leading suppliers.
- Emerging diagnostic technologies and their potential market applications.
- Product development opportunities.
- Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Business opportunities and strategic recommendations for suppliers.
Contains 620 pages and 103 tables
Table of Contents
Introduction
Worldwide Market and Technology Overview
A. Cancer Statistics and Etiology
1. Bladder
2. Breast
3. Cervical
4. Colon and Rectum
5. Endometrial
6. Esophagus
7. Head and Neck
8. Leukemia
9. Lung
10. Lymphoma
11. Oral
12. Ovarian
13. Prostate
14. Renal Cell Carcinoma
15. Skin
16. Stomach
17. Uterine
B. Major Current And Emerging Tumor Marker
1. Introduction
2. Tumor Marker Classification
3. ACTH
4. AlphaFetoprotein (AFP)
5. Beta2 Microglobulin
6. CA 153/27.29
7. CA 199
8. CA125
9. Calcitonin
10. Carcinoembrionic Antigen (CEA)
11. Estrogen and Progesterone Receptors
12. Ferritin
13. Gastrin
14. Human Chorionic Gonadotropin (HCG)
15. Insulin
16. Lymphocytes CD4/CD8
17. NSE
18. Occult Blood
19. PAP Smear/HPV
20. Prostatic Acid Phosphatase (PAP)
21. ProstateSpecific Antigen (PSA)
22. Squamous Cell Carcinoma Antigen (SCC)
23. TdT
24. Thyroglobulin
25. Tissue Polypeptide Antigen (TPA)
26. Biochemical Tumor Markers
ADA
BProtein
PNP
5'Nucleotidase
27. Oncogenes
Abl/ablbcr
AIB1
APC
BTA 26
BCL2
BCRABL
Braf
BRCA
CD44
CDK
Cabl
Cfos
Cmyb
Cmyc
CYCD1
CYP17
DPC
Emyc
ErbB
HER2/neu
HPC1
HSTF
Lmyc
MET
MSH
NEU
Nmyc
Ntelopeptide
PCA3
PIK3CA
PTI1
P10
P40
P51
P53
Ras
Reg
RET
sFas
Sis
Src
28. Polypeptide Growth Factors
Basic Fibroblast Growth Factor
BetaTGF
Cachectin (TNT)
Calmodulin
ECFR
Nerve Growth Factor (NGF)
Epidermal Growth Factor (EGF)
Ornithine Decarboxylase
Transferrin
Transforming Growth FactorAlpha
29. Ectopic Hormones
30. Colony Stimulating Factors
31. Lymphokines
AlphaInterferon
B Cell Growth Factors
B Cell Growth Factor (BCGF)
GammaInterferon
Interleukin1 (IL1)
Macrophage Activating Factor
32. Immunohistochemical Stains
33. Emerging Tumor Markers
NAcetylglucosamine
Actin
AlphaActin
Angiogenin
Angiostatin
Antineuronal Antibodies
7B2
B72.3
BProtein
Bax
BCDF9
BLCA4
Blood Group Antigens A,B,H
BTA
CA 50
CA 724/TAG72
CA 195
CA242
CA549
Cadherin
CAM 26
CAR3
CD105
CathepsinD
Chromogranin A and B
Cluster 1 Antigen
Cluster5/5A Antigen
COX Antigen
CTA
CU18
Cyclin
DR70
DUPAN2
Endometrial Bleeding Associated Factor
Endostatin
Epithelial Membrane Antigen
FDP
Feulgen Hydrolysis
Fibronectin
FSH
(1>3)Lfucosyltransferase
GastrinReleasing Peptide (GRP)
GDCFP15
Glucagon
Glycoamines
H23
HAAH
hk3
HPA
HSP27
Human Carcinoma Antigen
ICAM
Intermediate Filaments
Cytokeratins/CK18/Cyfra 211
Desmin
Gliofibrillary Acid Protein
Neurofilaments
Vimentin
KA 93
Kallikrein
Kinases
KP16D3
LAI
Leukocyte Common Antigen
Lewis Antigens
Lysophosphatidic Acid (LPA)
Ma 695/Ma 552
MABDF3
MAG
ME1
Minactivin
MN/CA9
MSA
Mucin Cancer Antigen (MCA)
Multiple Tumor Suppressor 1
Myosin
NEA130
NMP22
Nucleolar
OA519
Opiod Peptides
Pglycoprotein
Pancreatic Oncofetal Antigen (POA)
Parathyrcoid Hormone
Placental Lactogen
PR92
Proliferative Index, Ki67
Px
RB Inactivation/Deletion
Ret
S100 Protein
SCCL 175
Selectin
Serotonin
Sialic Acid
Sialyl SSEA1/SLX
SN10
Somatostatin
TA90
TABA
Tachykinin
TAG 12
TPS
Troponin
Tubulin
VCAM
VEGF
Villen
White Blood Cell Markers
C. Instrumentation Review And
Market Needs
1. Abbott AxSYM
2. Abbott IMx
3. Anagen AN2000/AuraFlex
4. Beckman Coulter Access
5. BioChem Pharma SR1
6. bioMerieux Vidas Series
7. Biotrol Systems 7000
8. J&J Diagnostics/Amersham Amerlite
9. J&J Diagnostics Vitros ECI
10. Olympus PK Series
11. Roche Cobas Core
12. Roche Elecsys
13. Roche ES 22
14. Roche ES 33
15. Roche ES 300/300 AL
16. Siemens ACS: 180
17. Siemens ACS: Centaur
18. Siemens ELISA Processor II/III
19. Siemens Immuno 1
20. Siemens/Opus/Plus/Magnum
21. Siemens Stratus
22. Tosoh AIA Series
23. Wallac/Pharmacia Delfia
D. Current and Emerging Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
Overview
ELISA
Immunofiltration
ParticleMembrane Capture Immunoassay
Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
Chemiluminescence
Bioluminescence
3. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
PCR
DAPPCR
ImmunoPCR
QCPCR
CAR
DNA
HPA
LCR
NASBA
QBR
SDA
3 SR, and others
4. Biochips/Microarrays
5. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas
Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
6. Microcomputers and Automation
7. Artificial Intelligence
8. Flow Cytometry
9. Biosensors
E. Competing/Complementing Technologies
1. CT
2. MRI
3. NMR
4. PET
5. Photonics Spectroscopy
F. Business Environment
1. Worldwide Market Structure
2. Worldwide Market Size and Growth
G. Personal Testing
U.S.A.
A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. HMO
b. PPO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
13. FDA Reform
C. Market Structure
1. Centralized Testing
a. Hospitals
b. Commercial/Private Laboratories
2. POT/Decentralized Testing
a. Physician Offices/Group Practices
b. Cancer Clinics
c. Other Decentralized Testing Locations
D. Market Size, Growth and Major Suppliers Sales,
Instrument Placements and Market Shares
Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Profiles
Abbott
AdnaGen
Ambrilia Biopharma
AMDL
Beckman Coulter
Becton Dickinson
Biomedical Diagnostics
bioMerieux
BioRad
CanAG Diagnostics
CeMines
Cepheid
Correlogic Systems
Dako
Decode
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
GenProbe
Guided Therapeutics
Hologic
Ipsogen
J&J Diagnostics
Kreatech
Kyowa Medex
Mackay Life Sciences
Matritech
Myriad Genetics
OncoLab
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Veridex
Wako Pure Chemicals
Wallac
Zila
Appendixes
Appendix I: Major Companies Developing or Marketing Tumor Marker Reagents
and Instruments
Appendix II: Major Universities and Research Centers Developing Tumor Marker Detection Technologies and Applications
Appendix III: Assumed Currency Exchange Rates
List of Tables
Tumor Marker Classification
Major Companies Developing or MarketingACTH Tests
Major Companies Developing or MarketingAFP Tests
Major Companies Developing or MarketingBeta2 Microglobulin Tests
Major Companies Developing or MarketingCA 153/27.29 Tests
Major Companies Developing or MarketingCA 199 Tests
Major Companies Developing or MarketingCA 125 Tests
Major Companies Developing or MarketingCalcitonin Tests
Major Companies Developing or MarketingCEA Tests
Major Companies Developing or MarketingEstrogen Receptor Tests
Major Companies Developing or MarketingProgesterone Receptor Tests
Major Companies Developing or MarketingFerritin Tests
Major Companies Developing or MarketingGastrin Tests
Major Companies Developing or MarketingHCG Tests
Major Companies Developing or MarketingInsulin Tests
Major Companies Developing or MarketingNSE Tests
Major Companies Developing or MarketingOccult Blood Tests
Major Companies Developing or MarketingPAP Smear/HPV Tests
Major Companies Developing or MarketingPAP Tests
Major Companies Developing or MarketingPSA Tests
Major Companies Developing or MarketingLymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or MarketingOncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Executive Summary Table: U.S., Total Tumor Marker Test Volume and Sales Forecast by Market Segment
U.S., Estimated New Cancer Cases and Deaths
U.S., Estimated Cancer Death Rates Per 100,000 Population
U.S., Laboratories Performing Tumor Marker Tests by Market Segment
U.S., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
U.S., Commercial/Private Laboratories Performing Tumor Marker Tests by
Annual Test Volume
U.S., Physician Office Laboratories Performing Tumor Marker Tests by Practice Size
U.S., Total Tumor Marker Test Volume Forecast by Market Segment
U.S., All Market Segments Major Tumor Marker Test Volume Forecast
U.S., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
U.S., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
U.S., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
U.S., Cancer Clinics Major Tumor Marker Test Volume Forecast by Assay
U.S., Total Tumor Marker Sales Forecast by Market Segment
U.S., All Market Segment Major Tumor Marker Sales Forecast by Test
U.S., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
U.S., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
U.S., Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
U.S., Cancer Clinics Major Tumor Marker Sales Forecast by Test
U.S., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Beta2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., CA 153/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., CA 199 Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., CA125 Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., CEA Test Volume and Diagnostics Sales by Market Segment
U.S., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Colonspecific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., S100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Total Tumor Marker Sales By Major Supplier
U.S., AFP Testing Market Diagnostics Sales by Major Supplier
U.S., CA 125 Testing Market Diagnostics Sales by Major Supplier
U.S., CA 153/27.29 Testing Market Diagnostics Sales by Major Supplier
U.S., CEA Testing Market Diagnostics Sales by Major Supplier
U.S., Ferritin Testing Market Diagnostics Sales by Major Supplier
U.S., HCG Testing Market Diagnostics Sales by Major Supplier
U.S., Insulin Testing Market Diagnostics Sales by Major Supplier
U.S., PAP Testing Market Diagnostics Sales by Major Supplier
U.S., PSA Testing Market Diagnostics Sales by Major Supplier
U.S., Tumor Marker Testing Instrumentation Major Systems Estimated Placements and
Installed Base by Supplier and Model
To order this report:
: US Tumor Marker Testing Market
Check our Real Time Industry Data
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article